3,6-Difluoropyrazine-2-carboxamide

Catalog No. :
ACDSIP483
CAS No. :
356783-29-4
Molecular Formula :
C5H3F2N3O
Molecular Weight :
159.10

IUPAC Name:3,6-difluoropyrazine-2-carboxamide

3,6-Difluoropyrazine-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$127.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6-Difluoropyrazine-2-carboxamide
IUPAC Name3,6-difluoropyrazine-2-carboxamide
MDL No.MFCD18968604
Molecular FormulaC5H3F2N3O
Molecular Weight159.10
SMILESO=C(C1=NC(F)=CN=C1F)N
InChI KeyWIQUNYNMYIJSCV-UHFFFAOYSA-N
Synonym3,6-difluoropyrazine-2-carboxaMide;Pyrazinecarboxamide, 3,6-difluoro- (9CI);Favipiravir Impurity 27;Des-(3-Oxo-3,4-dihydrogen) 3,6-Difluoro Favipiravir;2-Pyrazinecarboxamide, 3,6-difluoro-;Favipiravir Difluoro Impurity;Pyrazinecarboxamide, 3,6-difluoro-
CAS No.356783-29-4
PubChem CID22662861

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312+P330-P302+P352+P312-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P363-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDSIP483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFWKR873 route compound structure diagram
    ACFWKR873356783-28-3 In Stock
  2. Then
  3. ACDSIP483 route product structure diagram
    ACDSIP483356783-29-4 In Stock
Inquiry

2. ACDSIP483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  4. Plus
  5. ACFWKR873 route compound structure diagram
    ACFWKR873356783-28-3 In Stock
  6. Then
  7. ACDSIP483 route product structure diagram
    ACDSIP483356783-29-4 In Stock
Inquiry

Comments (0)